|09:30 – 09:45||Registration, refreshments and expenses|
|09:45 – 10:00||Welcome, introductions, UKCAB updates, Company pre-meeting|
|10:00 – 10:30||Gender and HIV research: history and overview – Polly Clayden, HIV i-Base|
|10:30 – 11.30||Outcomes in HIV positive women – Lucy Campbell, Kings College Hospital|
|11:30 – 11:40||Break|
|11:40 – 12:40||HIV and women’s issues – Prof. Jane Anderson|
|12:40 – 14:00||Lunch|
|14:00 – 15:30||Company meeting: BMS|
|15.30 – 15.35||Break|
|15:35 – 16:00||London HIV drug prescribing update and survey – Mark Platt|
1st International Workshop on Women From Adolescence through menopause
The full report from this meeting can be viewed online here:
Lopinavir/ritonavir LPV/r: women versus men
An analysis of on efficacy, safety and tolerability of LPV/r in women compared to men
Lessons from GRACE: A US Study Focused on Women Living with HIV
GRACE is the largest HIV/AIDS study to date in North America of HIV treatment experienced women. The study looked at whether darunavir/ritonavir (DRV/r) in combination with other ARVs would have a different effect in women compared to men. Black women were the focus of the GRACE Study because of the disproportionate effect that HIV/AIDS has in this population throughout the US.
It also is reportedly the longest ongoing disease progression study of HIV infection in women.
Quality of life in the GRACE study
The report looks at the quality of life in the study participants and how it impacted on discontinuing the study and virological response.
Antiretroviral pharmacokinetics in women with undetectable viral load
Considerations Regarding Antiretroviral Therapy in HIV-positive Women: Pharmacokinetics